Evidence map›Paper›PMID 38909237›Full record

ArticleBMC microbiology2024

The serine-rich repeat glycoprotein Srr2 mediates Streptococcus agalactiae interaction with host fibronectin.

Angelica Pellegrini, Chiara Motta, Elisa Bellan Menegussi, Andrea Pierangelini, Simona Viglio, Francesco Coppolino, Concetta Beninati, Vincenzo De Filippis, Giulia Barbieri, Giampiero Pietrocola

Abstract read
In one paragraph

Article in BMC microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Angelica PellegriniDepartment of Molecular Medicine, University of Pavia, Pavia, Italy.
Chiara MottaDepartment of Molecular Medicine, University of Pavia, Pavia, Italy.
Elisa Bellan MenegussiDepartment of Molecular Medicine, University of Pavia, Pavia, Italy.
Andrea PierangeliniDepartment of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy.
Simona ViglioDepartment of Molecular Medicine, University of Pavia, Pavia, Italy.
Francesco CoppolinoDepartment of Human Pathology and Medicine, University of Messina, Messina, Italy.
Concetta BeninatiDepartment of Human Pathology and Medicine, University of Messina, Messina, Italy.
Vincenzo De FilippisDepartment of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy.
Giulia BarbieriDepartment of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, Pavia, Italy. giulia.barbieri@unipv.it.
Giampiero PietrocolaDepartment of Molecular Medicine, University of Pavia, Pavia, Italy. giampiero.pietrocola@unipv.it.

Funding

CaRiPaRo Foundation Excellence Research Project BPiTA n. 52012EU funding within the Next-generation EU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases PE00000007, INF-ACTItalian Ministry for Universities and Research MUR-PRIN-2022 n. 2022ZSA2JP
6 · The paper itself

Abstract

backgroundGroup B Streptococcus (GBS) is a commensal of healthy adults and an important pathogen in newborns, the elderly and immunocompromised individuals. GBS displays several virulence factors that promote colonisation and host infection, including the ST-17 strain-specific adhesin Srr2, previously characterised for its binding to fibrinogen. Another common target for bacterial adhesins and for host colonization is fibronectin, a multi-domain glycoprotein found ubiquitously in body fluids, in the extracellular matrix and on the surface of cells.

resultsIn this study, fibronectin was identified as a novel ligand for the Srr2 adhesin of GBS. A derivative of the ST-17 strain BM110 overexpressing the srr2 gene showed an increased ability to bind fibrinogen and fibronectin, compared to the isogenic wild-type strain. Conversely, the deletion of srr2 impaired bacterial adhesion to both ligands. ELISA assays and surface plasmon resonance studies using the recombinant binding region (BR) form of Srr2 confirmed a direct interaction with fibronectin with an estimated Kd of 92 nM. Srr2-BR variants defective in fibrinogen binding also exhibited no interaction with fibronectin, suggesting that Srr2 binds this ligand through the dock-lock-latch mechanism, previously described for fibrinogen binding. The fibronectin site responsible for recombinant Srr2-BR binding was identified and localised in the central cell-binding domain of the protein. Finally, in the presence of fibronectin, the ability of a Δsrr2 mutant to adhere to human cervico-vaginal epithelial cells was significantly lower than that of the wild-type strain.

conclusionBy combining genetic and biochemical approaches, we demonstrate a new role for Srr2, namely interacting with fibronectin. We characterised the molecular mechanism of this interaction and demonstrated that it plays a role in promoting the adhesion of GBS to human cervico-vaginal epithelial cells, further substantiating the role of Srr2 as a factor responsible for the hypervirulence of GBS ST-17 strains. The discovery of the previously undescribed interaction between Srr2 and fibronectin establishes this adhesin as a key factor for GBS colonisation of host tissues.

Indexed as

Adhesins, BacterialBacterial AdhesionFibronectinsProtein BindingStreptococcus agalactiaeEpithelial CellsFemaleFibrinogenHumansStreptococcal InfectionsVirulence FactorsAdhesins, BacterialFibrinogenFibronectinsVirulence FactorsBacterial adhesinsDLL binding mechanismFibronectinHost-pathogen interactionSrr2 adhesinStreptococcus agalactiae

Identifiers

PMID38909237
PMCPMC11193222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.